Literature DB >> 12829824

Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus.

Kouacou V Konan1, Thomas H Giddings, Masanori Ikeda, Kui Li, Stanley M Lemon, Karla Kirkegaard.   

Abstract

The nonstructural proteins of hepatitis C virus (HCV) have been shown previously to localize to the endoplasmic reticulum (ER) when expressed singly or in the context of other HCV proteins. To determine whether the expression of HCV nonstructural proteins alters ER function, we tested the effect of expression of NS2/3/4A, NS4A, NS4B, NS4A/B, NS4B/5A, NS5A, and NS5B from genotype 1b HCV on anterograde traffic from the ER to the Golgi apparatus. Only the nominal precursor protein NS4A/B affected the rate of ER-to-Golgi traffic, slowing the rate of Golgi-specific modification of the vesicular stomatitis virus G protein expressed by transfection by approximately threefold. This inhibition of ER-to-Golgi traffic was not observed upon expression of the processed proteins NS4A and NS4B, singly or in combination. To determine whether secretion of other cargo proteins was inhibited by NS4A/B expression, we monitored the appearance of newly synthesized proteins on the cell surface in the presence and absence of NS4A/B expression; levels of all were reduced in the presence of NS4A/B. This reduction is also seen in cells that contain genome length HCV replicons: the rate of appearance of major histocompatibility complex class I (MHC-I) on the cell surface was reduced by three- to fivefold compared to that for a cured cell line. The inhibition of protein secretion caused by NS4A/B does not correlate with the ultrastructural changes leading to the formation a "membranous web" (D. Egger et al., J. Virol. 76:5974-5984, 2002), which can be caused by expression of NS4B alone. Inhibition of global ER-to-Golgi traffic could, by reducing cytokine secretion, MHC-I presentation, and transport of labile membrane proteins to the cell surface, have significant effects on the host immune response to HCV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829824      PMCID: PMC161946          DOI: 10.1128/jvi.77.14.7843-7855.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  81 in total

1.  Improved membrane preservation of flavivirus-infected cells with cryosectioning.

Authors:  J M Mackenzie; M K Jones; P R Young
Journal:  J Virol Methods       Date:  1996-01       Impact factor: 2.014

2.  Selection of recombinant vaccinia viruses on the basis of plaque formation.

Authors:  R Blasco; B Moss
Journal:  Gene       Date:  1995-06-09       Impact factor: 3.688

3.  Specificity of the hepatitis C virus NS3 serine protease: effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing.

Authors:  A A Kolykhalov; E V Agapov; C M Rice
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

4.  Genetic analysis of the nsP3 region of Sindbis virus: evidence for roles in minus-strand and subgenomic RNA synthesis.

Authors:  M W LaStarza; J A Lemm; C M Rice
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics.

Authors:  C Lin; B M Prágai; A Grakoui; J Xu; C M Rice
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

6.  Kinetic and structural analyses of hepatitis C virus polyprotein processing.

Authors:  R Bartenschlager; L Ahlborn-Laake; J Mous; H Jacobsen
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

7.  Processing in the pestivirus E2-NS2 region: identification of proteins p7 and E2p7.

Authors:  K Elbers; N Tautz; P Becher; D Stoll; T Rümenapf; H J Thiel
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini.

Authors:  C Lin; B D Lindenbach; B M Prágai; D W McCourt; C M Rice
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells.

Authors:  M W Cho; N Teterina; D Egger; K Bienz; E Ehrenfeld
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

10.  Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A.

Authors:  J R Doedens; K Kirkegaard
Journal:  EMBO J       Date:  1995-03-01       Impact factor: 11.598

View more
  50 in total

1.  High fidelity of yellow fever virus RNA polymerase.

Authors:  Konstantin V Pugachev; Farshad Guirakhoo; Simeon W Ocran; Fred Mitchell; Megan Parsons; Caroline Penal; Soheila Girakhoo; Svetlana O Pougatcheva; Juan Arroyo; Dennis W Trent; Thomas P Monath
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

Review 2.  Virus subversion of protective immunity.

Authors:  Eric W Hewitt; Gillian E Dugan
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

Review 3.  Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target.

Authors:  Kevin D Raney; Suresh D Sharma; Ibrahim M Moustafa; Craig E Cameron
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

4.  Regulated cleavages at the West Nile virus NS4A-2K-NS4B junctions play a major role in rearranging cytoplasmic membranes and Golgi trafficking of the NS4A protein.

Authors:  Jojanneke Roosendaal; Edwin G Westaway; Alexander Khromykh; Jason M Mackenzie
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 5.  Mechanisms of HCV survival in the host.

Authors:  Ella H Sklan; Prista Charuworn; Philip S Pang; Jeffrey S Glenn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

Review 6.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

7.  Endocytic Rab proteins are required for hepatitis C virus replication complex formation.

Authors:  David Manna; Jason Aligo; Chenjia Xu; Wei Sun Park; Hasan Koc; Won Do Heo; Kouacou V Konan
Journal:  Virology       Date:  2009-12-16       Impact factor: 3.616

8.  Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.

Authors:  Karla J Helbig; Andrew Ruszkiewicz; Robert E Lanford; Mark D Berzsenyi; Hugh A Harley; Shaun R McColl; Michael R Beard
Journal:  J Virol       Date:  2008-11-05       Impact factor: 5.103

9.  Modulation of hepatitis C virus genome encapsidation by nonstructural protein 4B.

Authors:  Qingxia Han; David Manna; Kerry Belton; Richard Cole; Kouacou V Konan
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

10.  Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.

Authors:  Jin Ye; Chunfu Wang; Rhea Sumpter; Michael S Brown; Joseph L Goldstein; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.